← Back to Search

Other

Tobacco cessation pharmacotherapy for Tobacco Cessation (Stepped Care Trial)

Phase 2 & 3
Waitlist Available
Led By Mark Vander Weg, PhD
Research Sponsored by Iowa City Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new way to help Veterans quit smoking, which may be more effective than existing methods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Tobacco cessation
Secondary study objectives
Salivary cotinine levels (in ng/ml)
Other study objectives
Level of satisfaction with the intervention as measured according to a five-point scale (extremely, very, moderately, slightly, not at all)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tailored InterventionExperimental Treatment2 Interventions
Tailored behavioral counseling combined with tobacco cessation pharmacotherapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tailored behavioral counseling
2017
N/A
~30

Find a Location

Who is running the clinical trial?

Iowa City Veterans Affairs Medical CenterLead Sponsor
7 Previous Clinical Trials
2,414 Total Patients Enrolled
US Department of Veterans AffairsFED
873 Previous Clinical Trials
497,748 Total Patients Enrolled
Mark Vander Weg, PhDPrincipal InvestigatorIowa City VA Health Care System
~19 spots leftby Dec 2025